References

  1.  World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. [Accessed 7 January 2021]
  2. ↑ Jump up to:2.0 2.1 National Institute for Health and Care Excellence (NICE), COVID-19 guideline scope: management of the long-term effects of COVID-19. 2020 [Accessed 7 January 2021].
  3. ↑ Jump up to:3.0 3.1 Perego E, Callard F, Stras L, Melville-Johannesson B, Pope R, Alwan N. Why we need to keep using the patient made term “Long Covid. BMJ Opinion. 2020 Oct 1 [Accessed 7 January 2021].
  4. ↑ Jump up to:4.0 4.1 Callard F, Perego E. How and why patients made Long Covid. Social Science & Medicine. 2020;268:113426.
  5.  Nature. Long COVID: let patients help define long-lasting COVID symptoms. 2020 October 7 [Accessed 7 January 2021].
  6. ↑ Jump up to:6.0 6.1 The BMJ. NICE guideline on long covid. 2020 December 23 [Accessed 7 January 2021].
  7. ↑ Jump up to:7.0 7.1 Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. 2020 December 16 [Accessed 7 January 2021].
  8.  Long-term effect of coronavirus (Long COVID). NHS, 2021.
  9.  E.Perego, F.Callard. Patient-made Long Covid changed COVID-19 (and the production of science, too). SocArXiv, 2021.
  10.  Nath A. Long-Haul COVID. Neurology. 2020;95(13):559-560.
  11.  Nature. The lasting misery of coronavirus long-haulers. 2020 September 14 [Accessed 7 January 2021].
  12.  Baig AM. Chronic COVID Syndrome: Need for An Appropriate Medical Terminology for Long‐COVID and COVID Long‐Haulers. Journal of Medical Virology. 2020;Oct 23.
  13.  World Health Organization. Global covid-19 clinical platform case report form (CRF) for post covid condition (Post COVID-19 CRF). 9 Feb 2021.
  14.  Goërtz YMJ, Herck MV, Delbressine JM, Vaes AW, Meys R et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. ERJ Open Research. 2020;6(4):1-10.
  15. ↑ Jump up to:15.0 15.1 NHS, National Guidance for Post-COVID Syndrome Assessment Clinics. 2020 November 6 [Accessed 7 January 2021].
  16.  Greenhalgh T, Knight M, Buxton M, Husain L. Management of Post-acute Covid-19 in Primary Care. BMJ. 2020;370:1-8.
  17. ↑ Jump up to:17.0 17.1 17.2 17.3 17.4 17.5 17.6 17.7 S.Rajan, K.Khunti, N.Alwan, C.Steves, T.Greenhalgh, N.MacDermott, A.Sagan, M.McKee. In the wake of the pandemic: preparing for Long COVID. World Health Organization regional office for Europe, 2021. Policy Brief 39.
  18. ↑ Jump up to:18.0 18.1 18.2 National Institute of Health Research. Living with Covid19. 2020 October 15 [Accessed 7 January 2021].
  19.  Watson S, Namiba A, Lynn V. The language of HIV: a guide for nurses. HIV Nursing. 2019;19(2):BP1-4.
  20. ↑ Jump up to:20.0 20.1 20.2 20.3 National Institute for Health and Care Excellence (NICE). COVID-19 Rapid Guideline: Managing The Long-term Effects of COVID-19. 2020 December 18 [Accessed 8 January 2021].
  21.  Public Health England. COVID-19: epidemiology, virology and clinical features. February 18, 2021.
  22.  L.Townsend, J.Dowds, K.O’Brien, G.Sheill, AH.Dyer, B.O’Kelly, JP.Hynes, A.Mooney, J.Dunne, CN.Cheallaigh, C.O’Farrelly, NM.Bourke, N.Conlon, I.Martin-Loeches, C.Bergin, P.Nadarajan,C.Bannan. Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Annals of the American Thoracic Society, 2021.
  23.  EL.Graham, JR.Clark, ZS.Orban, PH.Lim, AL.Szymanski, C.Taylor, RM.DiBiase, DT.Jia, R.Balabanov, SU.Ho, A.Batra, EM.Liotta, IJ.Koralnik.Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”. Annals of Clinical and Translational Neurology, 2021.
  24.  P.Brodin. Immune determinants of COVID-19 disease presentation and severity. Nature Medicine, 2021;27:28–33.
  25. ↑ Jump up to:25.0 25.1 Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, O’Connor L, Leavy D, O’Brien K, Dowds J, Sugrue JA. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. Plos one. 2020 Nov 9;15(11):e0240784.
  26.  M.Augustin, P.Schommers, M.Stecher, F.Dewald, L.Gieselmann, H.Gruell, C.Horn, K.Vanshylla, V.Di Cristanziano, L.Osebold, M.Roventa, T.Riaz, N.Tschernoster, J.Altmueller, L.Rose, S.Salomon, V.Priesner, JC.Luers, C.Albus, S.Rosenkranz, B.Gathof, G.Fätkenheuer, M.Hallek, F.Klein, I.Suárez, C.Lehmann. Recovered not restored: Long-term health consequences after mild COVID-19 in non-hospitalized patients. MedRxiv, 2021.
  27. ↑ Jump up to:27.0 27.1 27.2 JK.Logue, NM.Franko, DJ.McCulloch, D.McDonald, A.Magedson,CR.Wolf, HY.Chu. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021;4(2):e210830. doi:10.1001/jamanetworkopen.2021.0830
  28.  PHOSP-COVID Collaborative Group. Physical, cognitive and mental health impacts of COVID-19 following hospitalisation – a multi-centre prospective cohort study. MedRxiv, 2021.
  29. ↑ Jump up to:29.0 29.1 29.2 29.3 29.4 A.Dennis, M.Wamil, J.Alberts, J.Oben, DJ.Cuthbertson, D.Wootton, M.Crooks, M.Gabbay, M.Brady, L.Hishmeh, E.Attree, M.Heightman, R.Banerjee, A.Banerjee.Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391
  30. ↑ Jump up to:30.0 30.1 30.2 30.3 30.4 30.5 30.6 30.7 30.8 30.9 Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, Redfield S, Austin JP, Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. medRxiv. 2020 Jan 1.
  31.  Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens D, Hastie C, O’Hara M, Suett J, Burls A, Foote C, Carson G. Characterising long-term covid-19: a rapid living systematic review. medRxiv. 2020 Jan 1.
  32. ↑ Jump up to:32.0 32.1 N.Ziauddeen, D.Gurdasani, ME.O’Hara, C.Hastie, P.Roderick, G.Yao, NA.Alwan. Characteristics of Long Covid: findings from a social media survey. MedRxiv, 2021.
  33.  WHO Diaz JV, Soriano JB. A Delphi consensus to advance on a Clinical Case Definition for Post COVID-19 condition: A WHO protocol. 6.10.2021 Available: https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf (accessed11.10.2021)
  34. ↑ Jump up to:34.0 34.1 Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. Jama. 2020 Aug 11;324(6):603-5.
  35. ↑ Jump up to:35.0 35.1 Assaf G, Davis H, McCorkell L. Report: What Does COVID-19 Recovery Actually Look Like? An analysis of the prolonged COVID-19 symptoms survey by Patient-Led Research Team. Patient-Led Research [online]. Patient-Led Research. 2020.
  36.  Salmon-Ceron D, Slama D, Broucker TD. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study. J Infect. 2020.
  37. ↑ Jump up to:37.0 37.1 37.2 Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, Liang Kang, Li Guo, Min Liu, Xing Zhou, Jianfeng Luo, Zhenghui Huang, Shengjin Tu, Yue Zhao, Li Chen, Decui Xu, Yanping Li, Caihong Li, Lu Peng, Yong Li, Wuxiang Xie, Dan Cui, Lianhan Shang, Guohui Fan, Jiuyang Xu, Geng Wang, Ying Wang, Jingchuan Zhong, Prof Chen Wang, Prof Jianwei Wang, Dingyu Zhang, Prof Bin Cao. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 2021.
  38.  Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, Rizk D, Nasr L, Breyman E, Mohammadi N, Kellner C. Post-acute COVID-19 syndrome negatively impacts health and wellbeing despite less severe acute infection. medRxiv. 2020 Jan 1.
  39.  Centers for Disease Control and Prevention. Late Sequelae of COVID-19. 2020 November 13 [Accessed 8 January 2021].
  40.  Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. Morbidity and Mortality Weekly Report. 2020 Jul 31;69(30):993.
  41.  Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, Guessous I. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Annals of internal medicine. 2020 Dec 8.
  42.  Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E. Attributes and predictors of Long-COVID. Nature Medicine, 2021.
  43.  S.Lopez-Leon, T.Wegman-Ostrosky, C.Perelman, R.Sepulveda, P.Rebolledo, A.Cuapio, S.Villapol. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv, 2021.
  44.  S.Lopez-Leon, T.Wegman-Ostrosky, C.Perelman, R.Sepulveda, P.A.Rebolledo, A.Cuapio, S.Villapol. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv, 2021. https://doi.org/10.1101/2021.01.27.21250617
  45.  E.Garrigues, P.Janvier, Y.Kherabi, A.Le Bot, A.Hamon, H.Gouze, L.Doucet, S.Berkani, E.Oliosi, E.Mallart, F.Corre, V.Zarrouk, JD.Moyer, A.Galy, V.Honsel, B.Fantin, Y.Nguyen. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection, 2020; 81(6):E4-E6. DOI:https://doi.org/10.1016/j.jinf.2020.08.029
  46. ↑ Jump up to:46.0 46.1 Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal of medical virology. 2020 Jul 30.
  47.  O.Moreno-Perez, E.Merino, JM.Leon-Ramirez, M.Andres, JM.Ramos, J.Arenas-Jimenez, S.Asensio, R.Sanchez, P.Ruiz-Torregrosa, I.Galan, A.Scholz, A.Amo, P.Gonzalez-delaAleja, V.Boix, J.Gil. Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study. Journal of Infection, 2021. DOI:https://doi.org/10.1016/j.jinf.2021.01.004
  48. ↑ Jump up to:48.0 48.1 48.2 48.3 D.Munblit, P.Bobkova, E.Spiridonova, A.Shikhaleva, A.Gamirova, O.Blyuss, NA.Nekliudov, P.Bugaeva, M.Andreeva, A.DunnGalvin, P.Comberiati, C.Apfelbacher, J.Genuneit, S.Avdeev, V.Kapustina, A.Guekht, V.Fomin, AA.Svistunov,  P.Timashev, TM.Drake, S.Wulf Hanson, L.Merson, P.Horby, L.Sigfrid, JT.Scott, MG.Semple, JO.Warner, T.Vos, P.Olliaro, P.Glybochko, D.Butnaru. Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study. MedRxiv, 2021. doi: https://doi.org/10.1101/2021.02.17.21251895
  49. ↑ Jump up to:49.0 49.1 D Menges; T.Ballouz; A.Anagnostopoulos; HE.Aschmann; A.Domenghino; JS.Fehr; MA.Puhan. Estimating the burden of post-COVID-19 syndrome in a population-based cohort study of SARS-CoV-2 infected individuals: Implications for healthcare service planning. MedRxiv, 2021. https://doi.org/10.1101/2021.02.27.21252572
  50.  B.Osikomaiya, O.Erinoso, KO.Wright, AO.Odusola, B.Thomas, O.Adeyemi, A.Bowale, O.Adejumo, A.Falana, I.Abdus-salam, O.Ogboye, A.Osibogun, A.Abayomi. ‘Long COVID’: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infectious Diseases, 2021.
  51.  D.Ayoubkhani, K.Khunti, V.Nafilyan, T.Maddox, B.Humberstone, I.Diamond, A.Banerjee. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. MedRxiv, 2021. https://doi.org/10.1101/2021.01.15.21249885
  52. ↑ Jump up to:52.0 52.1 52.2 J.Scott, L.Sigfrid, T.Drake, E.Pauley, E.Jesudason, WS.Lim, D.Munblit, C.Hastie, E.Harrison, A.Docherty, P.Olliaro, P.Openshaw, K.Baillie, C.Semple for ISARIC4C Investigators. Symptoms and quality of life following hospitalisation for COVID-19 (Post COVID-19 Syndrome/Long COVID) in the ISARIC WHO Clinical Characterisation Protocol UK: preliminary results. 2021.
  53.  D.Buonsenso, D.Munblit, C.De Rose, D.Sinatti, A.Ricchiuto, A.Carfi, P.Valentini. Preliminary Evidence on Long COVID in children. MedRxiv, 2021. https://doi.org/10.1101/2021.01.23.21250375
  54.  Darren Brown for Long COVID Physio. What are common Long COVID symptoms? Available from https://youtu.be/9fogPLrZoQc [last accessed 22 March 2022]
  55.  Office for National Statistics. Coronavirus (COVID-19) Infection Survey, UK Statistical bulletins. [Accessed 8 January 2021]
  56.  Office for National Statistics. Updated estimates of the prevalence of long COVID symptoms. Released 21 January 2021. Accessed 21 January 2021.
  57.  Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y, Pan Y, Ke B, Li L, Guan Y, Mo X. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cellular & molecular immunology. 2020 Nov;17(11):1119-25.
  58.  Gaebler C, Wang Z, Lorenzi JC, Muecksch F, Finkin S, Tokuyama M, Ladinsky M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY. Evolution of Antibody Immunity to SARS-CoV-2. Nature. 2021 Jan 18.
  59.  De Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, Verillaud B, Aparicio C, Wagner S, Gheusi G, Kergoat L. COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system. bioRxiv. 2020 Jan 1.
  60.  Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, Volpe MC, Colliva A, Zanconati F, Berlot G, Silvestri F. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine. 2020 Nov 1;61:103104.
  61.  Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. International Journal of Infectious Diseases. 2020 Nov 1;100:327-32.
  62.  Woodruff MC, Ramonell RP, Lee FE, Sanz I. Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection. medRxiv. 2020 Jan 1.
  63.  BK.Patterson, J.Guevara-Coto, R.Yogendra, E.Francisco, E.Long, A.Pise, H.Rodrigues, P.Parikh, J.Mora, RA.Mora-Rodríguez. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. BioXriv, 2021. doi: https://doi.org/10.1101/2020.12.16.423122
  64.  Miller R, Wentzel AR, Richards GA. COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity. Medical Hypotheses. 2020 Nov 1;144:110044.
  65.  Vlachoyiannopoulos PG, Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, Tzioufas AG. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Annals of the Rheumatic Diseases. 2020 Dec 1;79(12):1661-3.
  66.  Wang EY, Mao T, Klein J, Dai Y, Huck JD, Liu F, Zheng NS, Zhou T, Israelow B, Wong P, Lucas C. Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv. 2020 Jan 1.
  67.  Shin Jie Yong. Persistent Brainstem Dysfunction in Long-COVID: A HypothesisACS Chem. Neurosci. 2021.https://doi.org/10.1021/acschemneuro.0c00793
  68.  E. Guedj, J. Y. Campion, P. Dudouet, E. Kaphan, F. Bregeon, H. Tissot-Dupont, S. Guis, F. Barthelemy, P. Habert, M. Ceccaldi, M. Million, D. Raoult, S. Cammilleri, C. Eldin. 18F-FDG brain PET hypometabolism in patients with long COVID. European Journal of Nuclear Medicine and Molecular Imaging, 2021. https://doi.org/10.1007/s00259-021-05215-4
  69.  DW.Nauen, JE.Hooper, M.Stewart, IH.Solomon. Assessing Brain Capillaries in Coronavirus Disease 2019. JAMA Neurology, 2021. doi:10.1001/jamaneurol.2021.0225
  70.  M.Boldrini, PD.Canoll, RS. Klein. How COVID-19 Affects the Brain. JAMA Psychiatry, 2021.
  71.  V.Mondelli, CM.Pariante. What can neuroimmunology teach us about the symptoms of long-COVID? Oxford Open Immunology, 2021.
  72.  J.Remsik, JA.Wilcox, NE.Babady, TA.McMillen, BA.Vachha, NA.Halpern, V.Dhawan, M.Rosenblum, CA.Iacobuzio-Donahue, EK.Avila, B.Santomasso, A.Boire. Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients. Cancer Cell 2021, 39; 2: p276-283.2021. DOI: https://doi.org/10.1016/j.ccell.2021.01.007
  73.  VO.Puntmann, M.Ludovica Carerj, I.Wieters, M.Fahim, C.Arendt, J.Hoffmann, A.Shchendrygina, F.Escher, M.Vasa-Nicotera, AM.Zeiher, M.Vehreschild, E.Nagel. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-1273. doi:10.1001/jamacardio.2020.3557
  74.  J.Abbasi. Researchers Investigate What COVID-19 Does to the Heart. JAMA Network, 2021. doi:10.1001/jama.2021.0107
  75.  T.Kotecha, DS.Knight, Y.Razvi, K.Kumar, K.Vimalesvaran, G.Thornton, R.Patel, L.Chacko, JT.Brown, C.Coyle, D.Leith, A.Shetye, B.Ariff, R.Bell, G.Captur, M.Coleman, J.Goldring, D.Gopalan, M.Heightman, T.Hillman, L.Howard, M.Jacobs, PS.Jeetley, P.Kanagaratnam, O.Min Kon, LE.Lamb, CH.Manisty, P.Mathurdas, J.Mayet, R.Negus, N.Patel, I.Pierce, G.Russell, A.Wolff, H.Xue, P.Kellman, JC.Moon, TA.Treibel, GD.Cole, M.Fontana. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. European Heart Journal, 2021. https://doi.org/10.1093/eurheartj/ehab075
  76.  M.Imazio. COVID-19 as a Possible Cause of Myocarditis and Pericarditis. American College of Cardiology, Expert Analysis, Feb 05 2021.
  77.  European Society of Cardiology (ECS) Guidance for the Diagnosis and Management of Cardiovascular Disease (CV) during the COVID-19 Pandemic. Last updated on 10 June 2020.
  78.  SL.Ramani, J.Samet, CK.Franz, C.Hsieh, CV.Nguyen, C.Horbinski, S.Deshmukh. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiology, 2021. https://doi.org/10.1007/s00256-021-03734-7
  79. ↑ Jump up to:79.0 79.1 Torjesen I. NICE cautions against using graded exercise therapy for patients recovering from covid-19. 2020 July 21 [Accessed 8 January 2021].
  80.  E.Ladds, A.Rushforth, S.Wieringa, S.Taylor, C.Rayner, L.Husain, T.Greenhalgh. Developing services for long COVID: lessons from a study of wounded healers. Clinical Medicine 2021 Vol 21, No 1: 59–65. DOI: https://doi.org/10.7861/clinmed.2020-0962
  81.  VV.Altiery De Jesús, N.Alwan, F.Callard, Z.Berger. Listening to Long COVID: Epistemic Injustice and COVID-19 morbidity. OSFPrePrints, 2021.
  82.  Klok FA, Boon GJ, Barco S, Endres M, Geelhoed JM, Knauss S, Rezek SA, Spruit MA, Vehreschild J, Siegerink B. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 2020 Jul 1;56(1).
  83.  Mohamed-Hussein A, Galal I, Saad M, Zayan HE, Abdelsayed M, Moustafa M, Ezzat AR, Helmy R, Abd Elaal H, Aly K, Abderheem S. Post-COVID-19 Functional Status: Relation to age, smoking, hospitalization and comorbidities. medRxiv. 2020 Jan 1.
  84. ↑ Jump up to:84.0 84.1 84.2 D’Cruz RF, Waller MD, Perrin F, Periselneris J, Norton S, Smith LJ, Patrick T, Walder D, Heitmann A, Lee K, Madula R. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Research. 2020 Jan 1.
  85.  FVC.Machado, R.Meys, JM.Delbressine, AW.Vaes, YMJ.Goërtz, M.van Herck, S.Houben-Wilke, GJAM.Boon, S.Barco, C.Burtin, A.van ‘t Hul, R.Posthuma, FME.Franssen, Y.Spies, H.Vijlbrief, F.Pitta, SA.Rezek, DJA.Janssen, B.Siegerink, FA.Klok, MA.Spruit. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021 Feb 3;19(1):40. doi: 10.1186/s12955-021-01691-2.
  86.  Sivan M, Halpin S, Gee J. Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool). Advances in Clinical Neurosciences and Rehabilitation. 2020 Jun 29;19(4):14-7.
  87.  Sivan M. Remote assessment for identifying COVID-19 post-acute care needs. Aging Clinical and Experimental Research. 2020 Oct;32(10):2167-8.
  88.  Tong A, Elliott JH, Azevedo LC, Baumgart A, Bersten A, Cervantes L, Chew DP, Cho Y, Cooper T, Crowe S, Douglas IS. Core outcomes set for trials in people with coronavirus disease 2019. Critical care medicine. 2020 Nov;48(11):1622.
  89.  A Tong, A Baumgart, Evangelidis N et al. Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery. Critical Care Medicine, 2021; 49(3): 503-516. DOI: 10.1097/CCM.0000000000004817
  90. ↑ Jump up to:90.0 90.1 Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020 Dec 3.
  91.  R.Núñez-Cortés, G.Rivera-Lillo, M.Arias-Campoverde, D. Soto-García, R.García-Palomera, R.Torres-Castro. Use of sit-to-stand test to assess the physical capacity and exertional desaturation in patients post COVID-19. Chronic Respiratory Disease, 2021.https://doi.org/10.1177/1479973121999205
  92.  Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, Okell T, Sheerin F, Xie C, Mahmod M, Mózes FE. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. medRxiv. 2020 Jan 1.
  93.  Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, Müller-Wieland D, Hartmann B, Dreher M, Müller T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respiratory medicine. 2020 Nov 1;174:106197.
  94.  Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L et al. Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase. Respiratory Research. 2020;21:163.
  95.  Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, Kurz K, Koppelstätter S, Haschka D, Petzer V, Hilbe R. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respiratory research. 2020 Dec;21(1):1-9.
  96.  Savarraj JP, Burkett AB, Hinds SN, Paz AS, Assing AR, Juneja S, Colpo GD, Torres LF, Gusdon AM, McCullough L, Choi HA. Three-month outcomes in hospitalized COVID-19 patients. medRxiv. 2020 Jan 1.
  97. ↑ Jump up to:97.0 97.1 Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of post-exertional malaise (PEM) in patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS): a patient-driven survey. Diagnostics. 2019 Mar;9(1):26.
  98. ↑ Jump up to:98.0 98.1 Jason LA, Sunnquist M. The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions. Frontiers in pediatrics. 2018 Nov 6;6:330.
  99. ↑ Jump up to:99.0 99.1 NICE. NICE draft guidance addresses the continuing debate about the best approach to the diagnosis and management of ME/CFS. 2020 November 10 [Accessed 8 January 2020].
  100.  J.Wise. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ 2021;372:n405. doi: https://doi.org/10.1136/bmj.n405
  101.  National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy) /chronic fatigue syndrome: diagnosis and management, In development [GID-NG10091] Expected publication date: 
  102.  Dialogues for a Neglected Illness (Dialogues for ME/CFS). Graded Exercise Therapy. [Accessed 8 January 2021]
  103.  Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AP, Speight N, Vallings R, Bateman L. Myalgic encephalomyelitis: international consensus criteria. Journal of internal medicine. 2011 Oct;270(4):327-38.
  104.  Stussman B, Williams A, Snow J, Gavin A, Scott R, Nath A, Walitt B. Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Neurology. 2020 Sep 18;11:1025.
  105.  Stephens C. MEA Summary Review: Assessing PEM (Post-exertional malaise). The ME Association. 2019 March 25 [Accessed 8 January 2021].
  106.  Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centered, cross-sectional survey. PloS one. 2018 Jun 1;13(6):e0197811.
  107.  Phelan D, Kim JH, Elliott MD, Wasfy MM, Cremer P, Johri AM et al. Screening of Potential Cardiac Involvemenappt in Competitive Athletes Recovering from COVID-19: An Expert Consensus Statement. JACC: Cardiovascular Imaging. 2020;13(12):2635-2652.
  108.  National Institute for Health Research (NIHR). Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN). [Accessed 8 January 2021]
  109.  Long Covid Physio. What is Long COVID?. Available from: https://www.youtube.com/watch?v=M4tGFiLXsIk [last accessed 23/3/2022]
  110.  Long Covid Physio. Why is it called Long COVID? Available from: https://www.youtube.com/watch?v=XVAXELKbG6M [last accessed 23/3/2022]

.